RNS Number : 6773A
PureTech Health PLC
24 January 2024
 

24 January 2024

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:             

23 January 2024



Number of ordinary shares purchased:

75,402



Highest price paid per share:

194.80p



Lowest price paid per share:

189.80p



Volume weighted average price paid per share:

191.64p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 18,849,671 ordinary shares in treasury and has 270,618,488 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 270,618,488 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

 

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

23/01/2024

08:03:44

522

191

XLON

00386666786TRLO0.1.1

23/01/2024

08:31:50

187

194.8

XLON

00386673684TRLO0.1.1

23/01/2024

08:32:39

648

194.8

XLON

00386674060TRLO0.1.1

23/01/2024

08:37:22

156

194.2

AQXE

00386675063TRLO0.1.1

23/01/2024

08:37:22

132

194.2

AQXE

00386675064TRLO0.1.1

23/01/2024

08:37:22

522

194.2

CHIX

00386675065TRLO0.1.1

23/01/2024

08:37:22

128

194.2

XLON

00386675066TRLO0.1.1

23/01/2024

08:37:22

1438

194.2

XLON

00386675067TRLO0.1.1

23/01/2024

08:50:30

97

193.6

TRQX

00386678519TRLO0.1.1

23/01/2024

08:50:30

77

193.6

TRQX

00386678520TRLO0.1.1

23/01/2024

09:09:34

288

193.6

AQXE

00386681494TRLO0.1.1

23/01/2024

09:09:34

62

193.6

AQXE

00386681495TRLO0.1.1

23/01/2024

09:09:34

522

193.6

BATE

00386681496TRLO0.1.1

23/01/2024

09:09:34

382

193.6

CHIX

00386681497TRLO0.1.1

23/01/2024

09:09:34

478

193.6

CHIX

00386681499TRLO0.1.1

23/01/2024

09:09:34

140

193.6

CHIX

00386681498TRLO0.1.1

23/01/2024

09:09:34

44

193.6

CHIX

00386681500TRLO0.1.1

23/01/2024

09:09:34

1126

193.6

XLON

00386681502TRLO0.1.1

23/01/2024

09:09:34

962

193.6

XLON

00386681501TRLO0.1.1

23/01/2024

09:09:34

174

193.6

TRQX

00386681503TRLO0.1.1

23/01/2024

09:09:36

980

193.6

XLON

00386681517TRLO0.1.1

23/01/2024

09:09:36

723

193.6

XLON

00386681518TRLO0.1.1

23/01/2024

09:22:10

82

193.2

BATE

00386683237TRLO0.1.1

23/01/2024

09:25:26

189

193.2

BATE

00386683851TRLO0.1.1

23/01/2024

09:34:26

23

193.8

XLON

00386685221TRLO0.1.1

23/01/2024

09:34:26

1847

193.8

XLON

00386685222TRLO0.1.1

23/01/2024

09:34:26

112

193.8

XLON

00386685223TRLO0.1.1

23/01/2024

09:35:04

711

193.8

XLON

00386685350TRLO0.1.1

23/01/2024

09:35:38

774

193.8

XLON

00386685437TRLO0.1.1

23/01/2024

09:36:30

757

193.8

XLON

00386685602TRLO0.1.1

23/01/2024

09:36:30

24

193.8

XLON

00386685603TRLO0.1.1

23/01/2024

09:37:17

522

194

XLON

00386685708TRLO0.1.1

23/01/2024

09:42:47

123

193.8

XLON

00386686491TRLO0.1.1

23/01/2024

09:42:47

399

194

XLON

00386686492TRLO0.1.1

23/01/2024

09:42:52

180

193.4

CHIX

00386686506TRLO0.1.1

23/01/2024

09:43:26

113

193.6

BATE

00386686620TRLO0.1.1

23/01/2024

09:50:59

47

193.6

BATE

00386687743TRLO0.1.1

23/01/2024

10:04:16

162

193.6

BATE

00386689895TRLO0.1.1

23/01/2024

10:04:16

362

193.6

BATE

00386689894TRLO0.1.1

23/01/2024

10:04:16

500

193.6

BATE

00386689896TRLO0.1.1

23/01/2024

10:04:16

20

193.6

BATE

00386689897TRLO0.1.1

23/01/2024

10:04:16

1552

193.6

XLON

00386689898TRLO0.1.1

23/01/2024

10:04:16

14

193.6

XLON

00386689899TRLO0.1.1

23/01/2024

10:04:16

966

193.6

XLON

00386689900TRLO0.1.1

23/01/2024

10:04:20

107

193

CHIX

00386689908TRLO0.1.1

23/01/2024

10:09:52

31

193

CHIX

00386690810TRLO0.1.1

23/01/2024

10:09:52

228

193

CHIX

00386690811TRLO0.1.1

23/01/2024

10:09:52

231

193

CHIX

00386690813TRLO0.1.1

23/01/2024

10:09:52

267

193

CHIX

00386690812TRLO0.1.1

23/01/2024

10:09:52

226

192.8

AQXE

00386690814TRLO0.1.1

23/01/2024

10:09:52

1383

193

XLON

00386690815TRLO0.1.1

23/01/2024

10:09:52

52

193

TRQX

00386690816TRLO0.1.1

23/01/2024

10:09:52

122

193

TRQX

00386690817TRLO0.1.1

23/01/2024

10:30:03

699

191.4

XLON

00386694222TRLO0.1.1

23/01/2024

10:30:03

84

191.4

XLON

00386694223TRLO0.1.1

23/01/2024

10:30:03

522

191.4

XLON

00386694224TRLO0.1.1

23/01/2024

10:30:03

142

191.4

XLON

00386694225TRLO0.1.1

23/01/2024

10:30:03

438

191.4

XLON

00386694226TRLO0.1.1

23/01/2024

10:52:11

464

191.4

XLON

00386698612TRLO0.1.1

23/01/2024

10:58:22

522

191.4

XLON

00386699839TRLO0.1.1

23/01/2024

12:36:13

44

191

TRQX

00386717726TRLO0.1.1

23/01/2024

12:36:13

174

191

TRQX

00386717727TRLO0.1.1

23/01/2024

12:47:00

288

191.6

AQXE

00386719326TRLO0.1.1

23/01/2024

12:54:03

729

191.6

CHIX

00386720518TRLO0.1.1

23/01/2024

12:54:03

315

191.6

CHIX

00386720519TRLO0.1.1

23/01/2024

13:28:55

288

191.8

AQXE

00386727257TRLO0.1.1

23/01/2024

13:45:30

178

191.2

AQXE

00386731423TRLO0.1.1

23/01/2024

13:45:30

244

191.2

BATE

00386731424TRLO0.1.1

23/01/2024

13:45:30

522

191.2

BATE

00386731425TRLO0.1.1

23/01/2024

13:45:30

110

191.2

AQXE

00386731426TRLO0.1.1

23/01/2024

13:45:30

278

191.2

BATE

00386731428TRLO0.1.1

23/01/2024

13:45:30

288

191.2

AQXE

00386731427TRLO0.1.1

23/01/2024

13:45:30

522

191.2

CHIX

00386731429TRLO0.1.1

23/01/2024

13:45:30

522

191.2

CHIX

00386731430TRLO0.1.1

23/01/2024

13:45:30

2088

191.2

XLON

00386731431TRLO0.1.1

23/01/2024

13:45:30

430

190.4

XLON

00386731432TRLO0.1.1

23/01/2024

13:45:30

513

190.4

XLON

00386731433TRLO0.1.1

23/01/2024

13:45:30

906

190.4

XLON

00386731434TRLO0.1.1

23/01/2024

13:45:30

2233

190.4

XLON

00386731435TRLO0.1.1

23/01/2024

13:45:34

1

190.6

BATE

00386731444TRLO0.1.1

23/01/2024

13:45:34

9

191

BATE

00386731445TRLO0.1.1

23/01/2024

13:46:59

150

190.8

BATE

00386731876TRLO0.1.1

23/01/2024

13:46:59

404

190.8

XLON

00386731877TRLO0.1.1

23/01/2024

13:46:59

182

190.8

XLON

00386731878TRLO0.1.1

23/01/2024

13:58:45

440

190.8

XLON

00386734649TRLO0.1.1

23/01/2024

13:58:47

112

190.8

XLON

00386734661TRLO0.1.1

23/01/2024

14:30:49

10

190.2

XLON

00386744883TRLO0.1.1

23/01/2024

14:31:19

10

190.2

XLON

00386745324TRLO0.1.1

23/01/2024

14:31:23

10

190.2

XLON

00386745407TRLO0.1.1

23/01/2024

14:31:23

500

190.2

CHIX

00386745408TRLO0.1.1

23/01/2024

14:31:23

522

190.2

BATE

00386745409TRLO0.1.1

23/01/2024

14:31:23

352

190.2

BATE

00386745410TRLO0.1.1

23/01/2024

14:31:23

22

190.2

CHIX

00386745411TRLO0.1.1

23/01/2024

14:31:23

349

190.2

CHIX

00386745412TRLO0.1.1

23/01/2024

14:31:23

1536

190.2

XLON

00386745413TRLO0.1.1

23/01/2024

14:31:23

1044

190.2

XLON

00386745414TRLO0.1.1

23/01/2024

14:31:23

101

190.2

BATE

00386745416TRLO0.1.1

23/01/2024

14:31:23

174

190.2

TRQX

00386745415TRLO0.1.1

23/01/2024

14:31:23

11

190.2

CHIX

00386745417TRLO0.1.1

23/01/2024

14:39:08

8

189.8

XLON

00386749366TRLO0.1.1

23/01/2024

14:39:12

10

189.8

XLON

00386749385TRLO0.1.1

23/01/2024

14:39:14

10

189.8

XLON

00386749400TRLO0.1.1

23/01/2024

14:39:19

10

189.8

XLON

00386749414TRLO0.1.1

23/01/2024

14:39:21

10

189.8

XLON

00386749436TRLO0.1.1

23/01/2024

14:39:23

10

189.8

XLON

00386749442TRLO0.1.1

23/01/2024

14:39:50

10

189.8

XLON

00386749654TRLO0.1.1

23/01/2024

14:54:08

522

191

BATE

00386756798TRLO0.1.1

23/01/2024

14:54:08

522

191

CHIX

00386756799TRLO0.1.1

23/01/2024

14:54:08

522

191

CHIX

00386756800TRLO0.1.1

23/01/2024

14:54:08

522

191

BATE

00386756801TRLO0.1.1

23/01/2024

14:54:08

2610

191

XLON

00386756802TRLO0.1.1

23/01/2024

14:54:08

174

191

TRQX

00386756803TRLO0.1.1

23/01/2024

15:11:47

288

190.2

AQXE

00386765005TRLO0.1.1

23/01/2024

15:35:51

39

191

XLON

00386776018TRLO0.1.1

23/01/2024

15:43:44

1800

190.8

XLON

00386779418TRLO0.1.1

23/01/2024

15:43:49

336

191.4

BATE

00386779458TRLO0.1.1

23/01/2024

15:50:13

227

191

CHIX

00386782043TRLO0.1.1

23/01/2024

15:50:13

708

191

BATE

00386782044TRLO0.1.1

23/01/2024

15:50:13

295

191

CHIX

00386782045TRLO0.1.1

23/01/2024

15:50:13

200

191

AQXE

00386782046TRLO0.1.1

23/01/2024

15:50:13

109

191

TRQX

00386782047TRLO0.1.1

23/01/2024

15:50:13

65

191

TRQX

00386782048TRLO0.1.1

23/01/2024

15:50:13

810

190.8

XLON

00386782049TRLO0.1.1

23/01/2024

15:50:13

1800

190.8

XLON

00386782050TRLO0.1.1

23/01/2024

16:19:59

522

190.4

CHIX

00386797323TRLO0.1.1

23/01/2024

16:19:59

522

190.4

BATE

00386797324TRLO0.1.1

23/01/2024

16:19:59

99

190.4

AQXE

00386797325TRLO0.1.1

23/01/2024

16:19:59

677

190.4

XLON

00386797327TRLO0.1.1

23/01/2024

16:19:59

277

190.4

AQXE

00386797326TRLO0.1.1

23/01/2024

16:19:59

170

190.4

XLON

00386797328TRLO0.1.1

23/01/2024

16:19:59

1763

190.4

XLON

00386797329TRLO0.1.1

23/01/2024

16:19:59

174

190.4

TRQX

00386797330TRLO0.1.1

23/01/2024

16:20:05

336

190.2

CHIX

00386797383TRLO0.1.1

23/01/2024

16:20:05

348

190.2

CHIX

00386797384TRLO0.1.1

23/01/2024

16:21:50

450

190.2

XLON

00386798141TRLO0.1.1

23/01/2024

16:21:50

1005

190.2

XLON

00386798142TRLO0.1.1

23/01/2024

16:24:56

522

190.8

CHIX

00386799811TRLO0.1.1

23/01/2024

16:24:57

460

190.8

XLON

00386799816TRLO0.1.1

23/01/2024

16:24:57

422

190.8

XLON

00386799817TRLO0.1.1

23/01/2024

16:25:03

13794

191

XLON

00386799846TRLO0.1.1

23/01/2024

16:25:03

413

191

XLON

00386799847TRLO0.1.1

23/01/2024

16:25:03

346

191

XLON

00386799848TRLO0.1.1

23/01/2024

16:29:33

89

190.8

XLON

00386801735TRLO0.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFITLTIVFIS